Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Hirsch

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Virology|February 26, 2010
Antiretroviral therapy in the clinicAthe M N Tsibris, Martin S Hirsch
The New England Journal of Medicine|July 19, 2008
Case records of the Massachusetts General Hospital. Case 22-2008. A 52-year-old woman with fever and confusionMartin S Hirsch, Alfred DeMaria, Pamela W Schaefer, et al.
The New England Journal of Medicine|February 28, 2019
Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and FeverJacob D Soumerai, Shahein H Tajmir, Martin S Hirsch, et al.
Antiviral Therapy|January 25, 2006
TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitroCécile L Tremblay, Françoise Giguel, Ting-Chao Chou, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitroCécile L Tremblay, Françoise Giguel, Yongbiao Guan, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitroCécile L Tremblay, Françoise Giguel, Christopher Kollmann, et al.
BMJ (Clinical Research Ed.)|March 11, 2006
Monitoring HIV treatment in developing countriesSerena P Koenig, Daniel R Kuritzkes, Martin S Hirsch, et al.
The Journal of Infectious Diseases|January 21, 2006
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapyAdriana Weinberg, Camlin Tierney, Michelle A Kendall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virusRajesh T Gandhi, Alysse Wurcel, Eric S Rosenberg, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitroCécile L Tremblay, Danielle L Poulin, Jennifer L Hicks, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Virology|February 26, 2010
Antiretroviral therapy in the clinicAthe M N Tsibris, Martin S Hirsch
The New England Journal of Medicine|July 19, 2008
Case records of the Massachusetts General Hospital. Case 22-2008. A 52-year-old woman with fever and confusionMartin S Hirsch, Alfred DeMaria, Pamela W Schaefer, et al.
The New England Journal of Medicine|February 28, 2019
Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and FeverJacob D Soumerai, Shahein H Tajmir, Martin S Hirsch, et al.
Antiviral Therapy|January 25, 2006
TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitroCécile L Tremblay, Françoise Giguel, Ting-Chao Chou, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitroCécile L Tremblay, Françoise Giguel, Yongbiao Guan, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitroCécile L Tremblay, Françoise Giguel, Christopher Kollmann, et al.
BMJ (Clinical Research Ed.)|March 11, 2006
Monitoring HIV treatment in developing countriesSerena P Koenig, Daniel R Kuritzkes, Martin S Hirsch, et al.
The Journal of Infectious Diseases|January 21, 2006
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapyAdriana Weinberg, Camlin Tierney, Michelle A Kendall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virusRajesh T Gandhi, Alysse Wurcel, Eric S Rosenberg, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitroCécile L Tremblay, Danielle L Poulin, Jennifer L Hicks, et al.
Pageof 5